Loading chat...

MO SB1724

Bill

Status

Introduced

2/25/2026

Primary Sponsor

Justin Brown

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Adds xylazine to Schedule III of Missouri's controlled substances list by amending section 195.017, RSMo

  • Provides exceptions allowing continued legal veterinary use of xylazine, including FDA-approved animal drugs, investigational use exemptions, pharmaceutical compounding by licensed pharmacists or veterinarians, and other uses permitted under federal law (21 U.S.C. Section 301, et seq.)

  • Xylazine is a veterinary sedative increasingly found mixed with fentanyl and other illicit drugs; scheduling would impose criminal penalties for unauthorized possession, distribution, and trafficking

  • Introduced by Senator Brown (District 16) during the Second Regular Session of the 103rd General Assembly

Legislative Description

Makes xylazine a Schedule III controlled substance

Last Action

S First Read

2/25/2026

Full Bill Text

No bill text available